Quantbot Technologies’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-47,500
Closed -$101K 1700
2023
Q3
$101K Buy
47,500
+38,200
+411% +$127K 0.01% 1096
2023
Q2
$44.3K Buy
9,300
+9,100
+4,550% +$50.2K ﹤0.01% 1331
2023
Q1
$1.14K Sell
200
-26,900
-99% -$162K ﹤0.01% 1473
2022
Q4
$273K Buy
27,100
+24,000
+774% +$451K 0.02% 784
2022
Q3
$69K Buy
+3,100
New +$89.6K 0.01% 1186
2021
Q4
Sell
-10,818
Closed -$641K 1643
2021
Q3
$641K Buy
10,818
+10,482
+3,120% +$822K 0.05% 516
2021
Q2
$29K Buy
336
+144
+75% +$11.6K ﹤0.01% 1168
2021
Q1
$15K Buy
192
+21
+12% +$2.01K ﹤0.01% 1204
2020
Q4
$15K Sell
171
-714
-81% -$44.3K ﹤0.01% 1050
2020
Q3
$35K Buy
+885
New +$30.9K ﹤0.01% 916
2020
Q1
Sell
-3,700
Closed -$72K 1049
2019
Q4
$72K Buy
3,700
+3,400
+1,133% +$54K 0.01% 893
2019
Q3
$4K Buy
+300
New +$5.75K ﹤0.01% 1211
2018
Q3
Sell
-74
Closed 1335
2018
Q2
$0 Sell
74
-10,910
-99% -$120K ﹤0.01% 1287
2018
Q1
$107K Buy
+10,984
New +$105K 0.01% 828

Other funds holding FATE